Top Industry Stories – July 29, 2009 « Medical Dynamics

THE LATEST WORD

Top Industry Stories – July 29, 2009

Posted on July 29th, 2009 | by Rxmedyn | No Comments »

“A look at the deal worked out on health care” (The Associated Press)
“Blue Dogs say they’ve reached a compromise on health care” (CNN.com)
“What Dangers Did Diprivan Pose to Michael Jackson?” (ABC News)
“ACADIA Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 5, 2009” (Press release issued by ACADIA Pharmaceuticals, Welt Online)
“Actelion mulls asthma marketing partnership” (Reuters)
“Watson Signs License Agreement With GeneraMedix” (Pharmaceutical Business Review)
“Israel stocks up; analysts weigh in on Teva as Nice surges” (MarketWatch)
“Pharma funding for medical classes draws scrutiny” (The Associated Press)
“Labopharm Confirms FDA Action Plan Submitted By Angelini” (Wall Street Journal)
“Drug stocks retreat; Bayer, Inovio jump” (MarketWatch)
“FORMA Therapeutics Announces Collaboration to Discover Inhibitors of Protein-Protein Interactions for Oncology” (Press release issued by FORMA Therapeutics, Business Wire)
“Pfizer Announces Partnership With Shanghai Institutes For Biological Sciences For Drug Discovery Activities” (Press release issued by Pfizer, Welt Online)
“Sanofi-Aventis’s Uncertain Prognosis” (Wall Street Journal)
“Agents search Jackson doc’s property in probe” (Baltimore Sun)
“Amgen boosts full-year forecast” (MSN Money)
“Glaxo pulls EU application for rare disease drug” (Reuters)
“AstraZeneca to push ahead with BTG sepsis drug” (Reuters)
“Industry donates to drug plan foes” (USA Today)
“Apotex Asks US Supreme Court To Overturn Plavix Patent” (Wall Street Journal)
“Medarex’s Pien Passes Up a Windfall” (Wall Street Journal)
“Many prostate cancers don’t need radical therapy” (Reuters)
“Pharma’s “Viking boss” makes generic-drug comeback” (Reuters)
“Sanofi-Aventis Announces Second Quarter 2009 Results” (Press release issued by Sanofi-Aventis, PRNewswire)
“Teva’s Net Falls on Merger Costs” (Wall Street Journal)
“Mylan reshuffles management” (Reuters)
“Bayer’s Net Beats Expectations” (Wall Street Journal)
“US FDA panel rejects King imaging drug data” (Reuters)
“New clients and higher prices lift Medco 2Q profit” (The Associated Press)
“Sanofi Said to Buy Rest of Merial Venture From Merck” (Bloomberg)
“Schering’s Antipsychotic Saphris Should Have Easy Advisory Committee Review” (The Pink Sheet)

Posted in Industry Stories

Leave a Reply

You must be logged in to post a comment.